Fig. 3
From: ADAR1 overexpression is associated with cervical cancer progression and angiogenesis
Disease-free survival curve of patients with ADAR1 positive and ADAR1 negative cervical squamous cell carcinoma. Overall disease-free survival time was 39.048 ± 1.118 months. Disease-free survival time of ADAR1 negative group was 45.458 ± 0.863 months, disease-free survival time of ADAR1 positive group was 34.877 ± 1.408. The difference was statistically significant (χ2 = 12.925, p < 0.001). 0 = ADAR1 negative group; 1 = ADAR1positive group